Authors: Alice Weatherston
A new study published recently in Nature Communications has highlighted a novel opportunity to slow the progression and reduce the symptoms of Huntington’s disease, utilizing healthy human brain cells. The findings could lead to a new therapeutic option for Huntington’s disease patients.
The research team isolated human glial progenitor cells, which give rise to repairing astrocytes, from embryonic stem cells and brain tissue and implanted the cells into the striatum of mice models of Huntington’s disease, where the majority of damage in the brains of Huntington’s disease patients is observed. Glia are important cells in the brain, providing support and protection for surrounding neurons.